Billerbeck, Germany (ots/PRNewswire) – The innovative dermis replacement MatriDerm® from MedSkin Solutions Dr. Suwelack AG is transforming soft tissue reconstruction and offering economic and medical benefits to current clinical practice
In a study led by Prof. Dragu, professor and head of plastic surgery at the University Hospital Dresden, the effectiveness of MatriDerm®, a dermis replacement from MedSkin Solutions Dr Suwelack AG, was demonstrated. The new publication, which marks a significant advance in reconstructive surgery, highlights the role of MatriDerm® in reducing operative time, avoiding flap surgery in up to 80% of cases, and eliminating donor site morbidity associated with traditional flap procedures are, emerge.
Jason Gugliuzza, Vice President & Head of the Medcare division explains: “MatriDerm® is designed to support the body’s natural healing process by providing a scaffolding structure for cell growth and skin regeneration. This not only accelerates recovery, but also significantly reduces the need for it for more invasive and costly surgical procedures. This study is not only significant for clinical practice, but also highlights the economic benefits of MatriDerm®.”
Economic and Medical Value of MatriDerm®
The economic impact of using MatriDerm® is profound. By reducing surgical time and eliminating flap surgeries, hospitals and healthcare facilities can use resources more efficiently, ultimately leading to cost savings and improved patient outcomes. In addition, patients benefit from a reduction in the risk of complications typical of flap surgery and therefore a faster return to their daily routine, underscoring the value of MatriDerm® in patient care.
Avoidance of flap surgeries and donor site defects
Prof. Dragu, author of the study, says: “Flap surgeries, although effective, come with their own challenges, including donor site morbidity, prolonged recovery times and the need for significant human resources. MatriDerm®’s ability to perform complex flap surgeries in most Avoiding cases in this specific patient population represents a significant shift in current treatment paradigms. This provides patients with a less invasive, but comparable and successful reconstructive outcome.”
Diana Ferro, CEO of MedSkin Solutions Dr Suwelack, added: “MatriDerm® is not just a dermal replacement; it is a solution that addresses the complex challenges of soft tissue reconstruction. The economic and medical benefits are consistent with our commitment to improvement patient outcomes and supporting healthcare systems worldwide.”
About MedSkin Solutions Dr. Suwelack AG
MedSkin Solutions Dr Suwelack AG is at the forefront of regenerative medicine and is committed to developing innovative solutions that improve patient care and outcomes. With a focus on research and development, MedSkin Solutions Dr Suwelack AG is committed to advancing healthcare through science and innovation.
Further information about MatriDerm® and MedSkin Solutions Dr. Suwelack, AG can be found at:
matriderm.com
medskin-suwelack.com
Logo:
View original content:
Questions & Contact:
Henrik Lesch,
MedSkin Solutions Dr. Suwelack AG,
Fuhlentwiete 14,
20355 Hamburg (D),
Deutschland,
T +49 40 356 204-711,
And hurry@medskin-suwelack.com
#study #redefines #reconstructive #surgery